Compare Fidelity National Information Servcs Inc (FIS) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fidelity National Information Servcs Inc vs Repligen Corporation Common Stock — how do they compare? Fidelity National Information Servcs Inc trades at $35.52 (market cap $18.15B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Fidelity National Information Servcs Inc is the larger of the two by market cap, and Fidelity National Information Servcs Inc pays a 5% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fidelity National Information Servcs Inc for 89 Days and Repligen Corporation Common Stock for 0 Days on average.
| FIS | RGEN | |
|---|---|---|
Market Cap | $18.15B | $11.14B |
Volume | 8,219,694 | 1,259,263 |
Sector | Technology | Health |
52-Week High | $67.94 | $194.57 |
52-Week Low | $32.44 | $102.87 |
Typical Hold Time | 89 Days | 0 Days |
Enterprise Value | $38.66B | $11.02B |
Dividend Yield | 5% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FIS trades at $35.47, up 3.53% with strong earnings beats in recent quarters. The stock shows bearish technical signals despite positive analyst sentiment with 57% buy ratings and a $45.50 consensus target. Fundamentals improved significantly with net income turning positive at $382 million in 2025 after prior losses, while revenue growth is projected to reach $12.2 billion in 2026. Recent business wins include core banking platform adoptions and embedded finance innovations.
FIS presents a compelling value opportunity with low P/E of 5.4 and strong profitability metrics, though technical indicators suggest near-term caution. Key risks include debt management challenges and competitive pressures in financial technology. The 27% upside to analyst targets and ongoing business momentum support a constructive outlook for patient investors.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fidelity National Information Servcs Inc
Fidelity National Information Services' legacy operations provide core and payment processing services to banks, but its business has expanded over time. By acquiring Sungard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS now provides payment processing services for merchants and holds leading positions in the United States and United Kingdom. About a fourth of revenue is generated outside North America.
Read more on FIS →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
